Supplementary Tables
Supplementary Table 1 -zearalenol*** D9-D10 300 nM 4-tert-cumylphenol*** H9-H10 10 M # For each ligand, the concentration used was determined prior to the screening experiment. It represents the dose at which the compound alone induces ≈30% of the luciferase expression obtained with 3 µM SR12813 (100% activation). *Compounds synthetized in the laboratory 4 . **Compounds purchased from Tocris Biosciences. ***Compounds purchased by Sigma Aldrich.****Gift from Sanofi Aventis. All compound stock solutions were prepared at 10 mM in DMSO. 
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